TSG6 exosomes for treatment of visual dysfunction as related to military-relevant trauma

Ended Project Grant Awarded Last action

Award ID
W81XWH2210697
Recipient
Awarding agency
Obligated
$737,512

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Funding
  • $368,756.00 Federal
  • $368,756.00 Non-federal
Place of performance
Memphis, TN 38103, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Original award $368,756 $368,756

Subawards

Subrecipient Amount Awarded
Diadem Biotherapeutics, Inc. Diadem Biotherapeutics, Inc proposes to develop exosomal TSG-6 as the first effective therapeutic to treat visual defects caused by neurotrauma. Closed globe… $41,800

Quick answers

Who received award W81XWH2210697?

W81XWH2210697 was awarded to University Of Tennessee by Defense Health Agency (Department of Defense) on July 15, 2022.

How much is award W81XWH2210697 worth?

$737,512 has been obligated on W81XWH2210697: $368,756 in federal funding and $368,756 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award